Applying In Vitro Tissue Models to Evaluate Target Expression & Anticipate Safety of Bispecific T Cell Engagers

  • Exploring tumor models in vitro to assess target engagement, cytotoxicity, and mechanistic outcomes beyond primary tumor efficacy
  • Profiling target expression across tissues to map potential off-tumor effects and guide tissue panel selection
  • Alternative in vitro safety models to anticipate potential toxicity liabilities